Impaired retinal vasodilator responses in prediabetes and type 2 diabetes

Acta Ophthalmologica

Volumn 91, Issue 6, 2013, Pages

  Lott, Mary E J ^a   Slocomb, Julia E ^a   Shivkumar, Vikram ^a   Smith, Bruce ^a   Quillen, David ^a   Gabbay, Robert A ^b   Gardner, Thomas W ^c   Bettermann, Kerstin ^a  

^a PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

^b PENN STATE COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF MICHIGAN   (United States)

Author keywords

flickering light stimulation; prediabetes; retinal reactivity; type 2 diabetes; vasodilation

Indexed keywords

C REACTIVE PROTEIN; GLUCOSE; INSULIN;

ADULT; AGED; ARTERY DIAMETER; ARTICLE; BLOOD VESSEL REACTIVITY; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETIC RETINOPATHY; FEMALE; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INSULIN SENSITIVITY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PHOTOSTIMULATION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RETINA ARTERY; RETINA BLOOD VESSEL; RETINA VEIN; VASODILATATION; VEIN DIAMETER;

FLICKERING LIGHT STIMULATION; PREDIABETES; RETINAL REACTIVITY; TYPE 2 DIABETES; VASODILATION;

BLOOD PRESSURE; C-REACTIVE PROTEIN; DIABETES MELLITUS, TYPE 2; DIABETIC RETINOPATHY; FEMALE; HEART RATE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MALE; MIDDLE AGED; PHOTIC STIMULATION; PREDIABETIC STATE; REGIONAL BLOOD FLOW; RETINAL VESSELS; VASODILATION;

EID: 84882611635     PISSN: 1755375X     EISSN: 17553768     Source Type: Journal    
DOI: 10.1111/aos.12129     Document Type: Article

References (55)

1. American Diabetes Association, (2010): Standards of medical care in diabetes-2010. Diabetes Care 33 (Suppl 1): S11-S61.
2. Antonetti DA, Klein R, &, Gardner TW, (2012): Diabetic retinopathy. N Engl J Med 366: 1227-1239.
3. Aronson D, Bartha P, Zinder O, Kerner A, Shitman E, Markiewicz W, Brook GJ, &, Levy Y, (2004): Association between fasting glucose and C-reactive protein in middle-aged subjects. Diabet Med 21: 39-44. (Pubitemid 38168027)
4. Bek T, Hajari J, &, Jeppesen P, (2008): Interaction between flicker-induced vasodilatation and pressure autoregulation in early retinopathy of type 2 diabetes. Graefes Arch Clin Exp Ophthalmol 246: 763-769.
5. Buckley DI, Fu R, Freeman M, Rogers K, &, Helfand M, (2009): C-reactive protein as a risk factor for coronary heart disease: a systematic review and meta-analyses for the U.S. Preventive Services Task Force. Ann Intern Med 151: 483-495.
6. Caballero AE, (2005): Metabolic and vascular abnormalities in subjects at risk for type 2 diabetes: the early start of a dangerous situation. Arch Med Res 36: 241-249. (Pubitemid 40755137)
7. Dehghan A, van Hoek M, Sijbrands EJ, Stijnen T, Hofman A, &, Witteman JC, (2007): Risk of type 2 diabetes attributable to C-reactive protein and other risk factors. Diabetes Care 30: 2695-2699. (Pubitemid 47547822)
8. Doi Y, Kiyohara Y, Kubo M, Ninomiya T, Wakugawa Y, Yonemoto K, Iwase M, &, Iida M, (2005): Elevated C-reactive protein is a predictor of the development of diabetes in a general Japanese population: the Hisayama Study. Diabetes Care 28: 2497-2500. (Pubitemid 41384300)
9. Dorner GT, Garhofer G, Huemer KH, Riva CE, Wolzt M, &, Schmetterer L, (2003a): Hyperglycemia affects flicker-induced vasodilation in the retina of healthy subjects. Vision Res 43: 1495-1500. (Pubitemid 36588802)
10. Dorner GT, Garhofer G, Kiss B, Polska E, Polak K, Riva CE, &, Schmetterer L, (2003b): Nitric oxide regulates retinal vascular tone in humans. Am J Physiol Heart Circ Physiol 285: H631-H636. (Pubitemid 36885894)
11. D'Souza A, Hussain M, Howarth FC, Woods NM, Bidasee K, &, Singh J, (2009): Pathogenesis and pathophysiology of accelerated atherosclerosis in the diabetic heart. Mol Cell Biochem 331: 89-116.
12. Festa A, Hanley AJ, Tracy RP, D'Agostino R Jr, &, Haffner SM, (2003): Inflammation in the prediabetic state is related to increased insulin resistance rather than decreased insulin secretion. Circulation 108: 1822-1830. (Pubitemid 37296091)
13. Ford ES, Zhao G, &, Li C, (2010): Pre-diabetes and the risk for cardiovascular disease: a systematic review of the evidence. J Am Coll Cardiol 55: 1310-1317.
14. Garhofer G, Zawinka C, Resch H, Kothy P, Schmetterer L, &, Dorner GT, (2004): Reduced response of retinal vessel diameters to flicker stimulation in patients with diabetes. Br J Ophthalmol 88: 887-891.
15. Garhofer G, Bek T, Boehm AG, et al., (2010): Use of the retinal vessel analyzer in ocular blood flow research. Acta Ophthalmol 88: 717-722.
16. Haffner SM, (2003): Pre-diabetes, insulin resistance, inflammation and CVD risk. Diabetes Res Clin Pract 61 (Suppl 1): S9-S18. (Pubitemid 36918317)
17. Hu G, Jousilahti P, Tuomilehto J, Antikainen R, Sundvall J, &, Salomaa V, (2009): Association of serum C-reactive protein level with sex-specific type 2 diabetes risk: a prospective Finnish study. J Clin Endocrinol Metab 94: 2099-2105.
18. Katz A, Nambi SS, Mather K, Baron AD, Follmann DA, Sullivan G, &, Quon MJ, (2000): Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab 85: 2402-2410. (Pubitemid 32269192)
19. Kifley A, Wang JJ, Cugati S, Wong TY, &, Mitchell P, (2008): Retinal vascular caliber and the long-term risk of diabetes and impaired fasting glucose: the Blue Mountains Eye Study. Microcirculation 15: 373-377. (Pubitemid 351927726)
20. King DE, Mainous AG 3rd, Buchanan TA, &, Pearson WS, (2003): C-reactive protein and glycemic control in adults with diabetes. Diabetes Care 26: 1535-1539. (Pubitemid 36929192)
21. Klein BE, Klein R, Lee KE, Knudtson MD, &, Tsai MY, (2006): Markers of inflammation, vascular endothelial dysfunction, and age-related cataract. Am J Ophthalmol 141: 116-122. (Pubitemid 43016180)
22. Kneser M, Kohlmann T, Pokorny J, &, Tost F, (2009): Age related decline of microvascular regulation measured in healthy individuals by retinal dynamic vessel analysis. Med Sci Monit 15: CR436-CR441.
23. Kondo M, Wang L, &, Bill A, (1997): The role of nitric oxide in hyperaemic response to flicker in the retina and optic nerve in cats. Acta Ophthalmol Scand 75: 232-235. (Pubitemid 27315582)
24. Kotliar KE, Lanzl IM, Schmidt-Trucksass A, Sitnikova D, Ali M, Blume K, Halle M, &, Hanssen H, (2011): Dynamic retinal vessel response to flicker in obesity: a methodological approach. Microvasc Res 81: 123-128.
25. Kullo IJ, Malik AR, Santos S, Ehrsam JE, &, Turner ST, (2007): Association of cardiovascular risk factors with microvascular and conduit artery function in hypertensive subjects. Am J Hypertens 20: 735-742. (Pubitemid 46936166)
26. Lippincott MF, Carlow A, Desai A, et al., (2008): Relation of endothelial function to cardiovascular risk in women with sedentary occupations and without known cardiovascular disease. Am J Cardiol 102: 348-352.
27. Lott ME, Slocomb JE, Shivkumar V, Smith B, Gabbay RA, Quillen D, Gardner TW, &, Bettermann K, (2012): Comparison of retinal vasodilator and constrictor responses in type 2 diabetes. Acta Ophthalmol 90: e434-e441.
28. Mandecka A, Dawczynski J, Blum M, et al., (2007): Influence of flickering light on the retinal vessels in diabetic patients. Diabetes Care 30: 3048-3052. (Pubitemid 350255244)
29. Mazzone T, Chait A, &, Plutzky J, (2008): Cardiovascular disease risk in type 2 diabetes mellitus: insights from mechanistic studies. Lancet 371: 1800-1809. (Pubitemid 351697956)
30. Meng YX, Ford ES, Li C, Quarshie A, Al-Mahmoud AM, Giles W, Gibbons GH, &, Strayhorn G, (2007): Association of C-reactive protein with surrogate measures of insulin resistance among nondiabetic US from National Health and Nutrition Examination Survey 1999-2002. Clin Chem 53: 2152-2159. (Pubitemid 350197299)
31. Michelson G, Patzelt A, &, Harazny J, (2002): Flickering light increases retinal blood flow. Retina 22: 336-343. (Pubitemid 36150599)
32. Milman S, &, Crandall JP, (2011): Mechanisms of vascular complications in prediabetes. Med Clin North Am 95: 309-325, vii.
33. Muniyappa R, &, Quon MJ, (2007): Insulin action and insulin resistance in vascular endothelium. Curr Opin Clin Nutr Metab Care 10: 523-530. (Pubitemid 46934125)
34. Muniyappa R, Lee S, Chen H, &, Quon MJ, (2008): Current approaches for assessing insulin sensitivity and resistance in vivo: advantages, limitations, and appropriate usage. Am J Physiol Endocrinol Metab 294: E15-E26.
35. Nagel E, &, Vilser W, (2004): Flicker observation light induces diameter response in retinal arterioles: a clinical methodological study. Br J Ophthalmol 88: 54-56. (Pubitemid 38091362)
36. Nakanishi N, Shiraishi T, &, Wada M, (2005): Association between C-reactive protein and insulin resistance in a Japanese population: the Minoh Study. Intern Med 44: 542-547. (Pubitemid 40932825)
37. Nguyen TT, Kawasaki R, Wang JJ, Kreis AJ, Shaw J, Vilser W, &, Wong TY, (2009): Flicker light-induced retinal vasodilation in diabetes and diabetic retinopathy. Diabetes Care 32: 2075-2080.
38. Pemp B, Garhofer G, Weigert G, Karl K, Resch H, Wolzt M, &, Schmetterer L, (2009a): Reduced retinal vessel response to flicker stimulation but not to exogenous nitric oxide in type 1 diabetes. Invest Ophthalmol Vis Sci 50: 4029-4032.
39. Pemp B, Weigert G, Karl K, Petzl U, Wolzt M, Schmetterer L, &, Garhofer G, (2009b): Correlation of flicker-induced and flow-mediated vasodilatation in patients with endothelial dysfunction and healthy volunteers. Diabetes Care 32: 1536-1541.
40. Pournaras CJ, Rungger-Brandle E, Riva CE, Hardarson SH, &, Stefansson E, (2008): Regulation of retinal blood flow in health and disease. Prog Retin Eye Res 27: 284-330.
41. Ridker PM, (2004): High-sensitivity C-reactive protein, inflammation, and cardiovascular risk: from concept to clinical practice to clinical benefit. Am Heart J 148: S19-S26. (Pubitemid 38887094)
42. Ridker PM, Rifai N, Pfeffer MA, Sacks F, &, Braunwald E, (1999): Long-term effects of pravastatin on plasma concentration of C-reactive protein. The Cholesterol and Recurrent Events (CARE) Investigators. Circulation 100: 230-235. (Pubitemid 29340127)
43. Sabanayagam C, &, Shankar A, (2011): Association between plasma homocysteine and microalbuminuria in persons without hypertension, diabetes mellitus, and cardiovascular disease. Clin Exp Nephrol 15: 92-99.
44. Schmetterer L, &, Wolzt M, (1999): Ocular blood flow and associated functional deviations in diabetic retinopathy. Diabetologia 42: 387-405. (Pubitemid 29148397)
45. Schmetterer L, Findl O, Fasching P, et al., (1997): Nitric oxide and ocular blood flow in patients with IDDM. Diabetes 46: 653-658. (Pubitemid 27143383)
46. Sun C, Wang JJ, Mackey DA, &, Wong TY, (2009): Retinal vascular caliber: systemic, environmental, and genetic associations. Surv Ophthalmol 54: 74-95.
47. Tan KC, Chow WS, Tam SC, Ai VH, Lam CH, &, Lam KS, (2002): Atorvastatin lowers C-reactive protein and improves endothelium-dependent vasodilation in type 2 diabetes mellitus. J Clin Endocrinol Metab 87: 563-568. (Pubitemid 34158219)
48. Terai N, Spoerl E, Pillunat LE, &, Stodtmeister R, (2012): The effect of caffeine on retinal vessel diameter in young healthy subjects. Acta Ophthalmol 90: e524-e528.
49. Thomsen SB, Rathcke CN, Zerahn B, &, Vestergaard H, (2010): Increased levels of the calcification marker matrix Gla Protein and the inflammatory markers YKL-40 and CRP in patients with type 2 diabetes and ischemic heart disease. Cardiovasc Diabetol 9: 86.
50. Tilma KK, &, Bek T, (2012): Topical treatment for 1 week with latanoprost but not diclofenac reduces the diameter of dilated retinal arterioles in patients with type 1 diabetes mellitus and mild retinopathy. Acta Ophthalmol 90: 750-755.
51. Toda N, Imamura T, &, Okamura T, (2010): Alteration of nitric oxide-mediated blood flow regulation in diabetes mellitus. Pharmacol Ther 127: 189-209.
52. Vita JA, Keaney JF Jr, Larson MG, et al., (2004): Brachial artery vasodilator function and systemic inflammation in the Framingham Offspring Study. Circulation 110: 3604-3609. (Pubitemid 39612578)
53. Wilson PW, Pencina M, Jacques P, Selhub J, D'Agostino R Sr, &, O'Donnell CJ, (2008): C-reactive protein and reclassification of cardiovascular risk in the Framingham Heart Study. Circ Cardiovasc Qual Outcomes 1: 92-97.
54. Wong TY, Islam FM, Klein R, Klein BE, Cotch MF, Castro C, Sharrett AR, &, Shahar E, (2006): Retinal vascular caliber, cardiovascular risk factors, and inflammation: the multi-ethnic study of atherosclerosis (MESA). Invest Ophthalmol Vis Sci 47: 2341-2350. (Pubitemid 351639814)
55. Wu T, Dorn JP, Donahue RP, Sempos CT, &, Trevisan M, (2002): Associations of serum C-reactive protein with fasting insulin, glucose, and glycosylated hemoglobin: the Third National Health and Nutrition Examination Survey, 1988-1994. Am J Epidemiol 155: 65-71. (Pubitemid 34042434)